; (2) information relating to individuals experiencing Long COVID and related conditions and other information available through the voluntary patient registry; (3) dissemination of information to relevant Federal departments and agencies and patients participating in the voluntary patient registry related to COVID–19, Long COVID, and related conditions; (4) an assurance that the voluntary patient registry utilizes common data elements and definitions for use in order to promote appropriate data sharing for ongoing and future research; and (5) outreach to, and inclusion in the voluntary patient registry, as appropriate, of individuals from communities impacted by high COVID–19 and Long COVID rates and health care providers from diverse disciplines that may treat individuals with COVID–19, Long COVID, and related conditions. (c) Voluntary participation